US EditionPublished • loading... • Updated
Recalled supplement linked to reported salmonella outbreak, FDA says
The recall involves 52 lots linked to a salmonella strain resistant to common antibiotics, with seven cases reported across seven states, officials said.
- On Feb. 13, Ambrosia Brands LLC recalled 52 lots of Rosabella moringa capsules after the Food and Drug Administration linked them to a multi-state Salmonella newport outbreak.
- Investigators found at least seven infections across seven states between Nov. 7, 2025 and Jan. 8, 2026 involving a Salmonella newport strain with an NDM-1 gene resistant to common antibiotics.
- The capsules were distributed online on tryrosabella.com and TikTok Shop, with lots starting sku 1356 ending in-1 or-2 and expiration dates from 03/2027 to 11/2027.
- Consumers should immediately stop using affected bottles, discard or return them for full refunds, and contact Ambrosia Brands at 914-768-1357 Monday through Friday for questions.
- The CDC says this is a second moringa‑linked outbreak in recent months, but official counts likely underrepresent true illnesses, with only one in 30 cases reported.
Insights by Ground AI
12 Articles
12 Articles
Coverage Details
Total News Sources12
Leaning Left3Leaning Right0Center8Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
L 27%
C 73%
Factuality
To view factuality data please Upgrade to Premium
